PLGD is autosomal recessive; clinical disease typically requires a pathogenic variant in both alleles of the PLG gene (one from each parent). There are two types:
Type II appears to be more common than type I.
Penetrance is variable; disease severity can differ in individuals with the same genotype, even within the same kindred. Diagnosis is often delayed for months to years. Genetic testing can be done but is not required. Results of genetic testing do not predict disease severity or the need for treatment.
CNS: central nervous system; IBD: inflammatory bowel disease; JCM: juvenile colloid milium; PLGD: plasminogen deficiency; TXA: tranexamic acid.
* Reference ranges may vary by laboratory; use the reference range provided by the laboratory and clinical judgment.
¶ Need for treatment and treatment options are presented separately in UpToDate.
Δ Most common presenting finding; refer to UpToDate for description and images.